Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
United States of America et al v. Genzyme Corporation
Case Number:
8:09-cv-01245
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
March 12, 2014
NJ, Fla. To Get Slices Of $22M Genzyme FCA Settlement
The state of New Jersey has joined a $22 million settlement to resolve former Genzyme Corp. employees' False Claims Act allegations in Florida federal court that the company marketed its Seprafilm adhesion barrier for unapproved uses, Acting Attorney General John J. Hoffman said Wednesday.
-
August 26, 2011
Doc Says Tampa Firm Cut Him Out Of Genzyme Qui Tam
A surgeon asked a Florida federal judge Friday for permission to intervene as a plaintiff in a qui tam lawsuit accusing Genzyme Corp. of improperly marketing its Seprafilm adhesion barrier, alleging the current plaintiffs' firm unfairly cut him out of the case.